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In the past, many attempts have been made to correlate tumor immunity and/or
tumor rejection with the presence of cytolytic T lymphocytes (CTL)' within the
tumor mass (1, 2) . Most of these attempts have failed, with some notable exceptions
(3-9) . One of the reasons for the failures may have been the lack of sensitive assay
systems for the detection of small numbers of CTL and their precursors . In most
tumor systems, CTL are at best formed in small numbers and appear only transiently,
or they may be present in the form of noncytolytic CTL precursors (CTL-P) or
memory CTL-P, which can only be detected in secondary responses.
Fewer difficulties in detecting CTL have been encountered in studies of the
Moloney sarcoma-leukemia virus (MSV-MoLV) -induced tumor system . This system
is characterized by the formation of highly immunogenic tumors that regress spon-
taneously . Before and at the time of tumor regression, CTL specific for MoLV-
associated cell surface antigens appear not only in lymphoid organs and blood of the
tumor-bearing animals (10), but also in the tumor itself (4-7) . The detection of these
CTL, however, required a 20-h 51Cr release assay using highly sensitive lymphoma
target cells, suggesting the presence of relatively few cytolytic effector cells . On the
other hand, cells from lymphoid organs (11) and tumors (12) of such animals gave
secondary type CTL responses when stimulated in vitro with syngeneic tumor cells,
demonstrating the presence of (memory) CTL-P able to rapidly generate CTL readily
detectable in a 6-h assay .
Kinetic studies of CTL formation in the MSV-MoLV system have revealed peak
CTL activities in lymph nodes and blood at the time ofmaximum tumor diameter,
whereas intratumoral cells showed peak activity at the onset oftumor regression (5) .
However, no accurate studies comparing the relative frequency of CTL and/or
CTL-P in blood and tumor were carried out, i.e ., the question of the possible selective
accumulation of CTL and their precursors in the tumor was not resolved .
Methods facilitating the detection, quantitation, and clonal analysis of antigen-
Abbreviations used in this paper: CTL, cytolytic T lymphocyte ; CTL-P, CTL precursor cell ; DMEM,
Dulbecco's modified Eagle's medium ; FBS, fetal bovine serum ; MSV, Moloney sarcoma virus ; MoLV,
Moloney leukemia virus ; MLC, mixed leukocyte culture ; 2° MLC SN, secondaryMLC supernate ; MLTC,
mixed leukocyte-tumor cell culture ; micro-MLTC, MLTC microculture system ; PBL, peripheral blood
leukocytes; TCGF, T cell growth factor.
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reactive T lymphocytes have recently been described . They are based on the use ofT
cell growth factor (TCGF) or interleukin 2 as a nonspecific stimulant able to induce
and/or maintain the in vitro proliferation ofantigen-activated T cells, including CTL
(13) . The efficacy ofTCGF in promoting in vitro the proliferation of small numbers
of CTL infiltrating solid 3-methylcholanthrene-induced tumors was recently demon-
strated (9) .
In our own studies of CTL generation in vivo and in vitro in the MSV-MoLV
system, we have shown that small (limiting) numbers of tumor-specific CTL-P could
respond under clonal conditions to antigenic stimulation in mixed leukocyte-tumor
cell microcultures (micro-MLTC), provided that TCGF and accessory cells in the
form of syngeneic irradiated spleen cells were added (14, 15) . Not only CTL-P but
also mature CTL responded with high cloning efficiency, i.e ., CTL behaved opera-
tionally like CTL-P (15) . Thus it was possible to obtain minimal estimates of the
frequency ofCTL and of their precursors contained in various cell populations, and
to study the progeny derived, at least theoretically, from single CTL-P .
In the present study, we have applied this technique to the determination of
CTL-P frequencies in cells infiltrating primary MSV-MoLV-induced tumors at the
onset of tumor regression . It will be shown that the tumors contained higher
frequencies of MoLV-specific CTL-P than either blood or spleen of the same tumor-
bearing animals, demonstrating selective accumulation ofCTL-P in the tumor mass
at the time of rejection .
Materials and Methods
Mice.
￿
Inbred C57BL/6 mice were provided by the animal colony maintained at the Swiss
Institute .for Experimental Cancer Research, Epalinges, Switzerland . The original breeding
pairs were obtained from The Jackson Laboratory, Bar Harbor, Maine .
Tumors.
￿
MSV tumors were induced in 4-wk-old female C57BL/6 mice by intramuscular
injection in the thigh of 0 .1 ml of a cell-free tumor homogenate containing the MSV-MoLV
complex .
Tumor Cell Lines.
￿
MBL-2 (H-2~, a MoLV-induced lymphoma, was maintained by serial
passage of the ascitic form in female C57BL/6 mice. LSTRA (H-2d), a MoLV-induced
lymphoma, P815 (H-2d
) and EL4 (H-2), both chemically induced tumors, were maintained in
vitro in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal bovine
serum (FBS) .
Lymphoid Cells.
￿
10 d after MSV-MoLV injection, spleens, blood, and tumors of groups of
five mice were collected and a pool of lymphoid cells was prepared as described previously (5) .
Briefly, spleens were cut into large fragments, suspended in DMEM, and homogenized in
Tenbroeck glass homogenizers (Bellco Glass, Inc ., Vineland, N . J .) . Debris was allowed to
sediment for 20 min at unit gravity, and cells in the supernate were washed twice in DMEM .
Peripheral blood leukocytes (PBL) were obtained by mixing 1 vol of blood with 2 vol of 2.4%
poly-vinyl-pyrolidone containing 5 IU/ml heparin . After sedimentation of the erythrocytes at
unit gravity for 45 min, the supernates were centrifuged at 1,400 g for 10 min and the cells in
the pellet were washed twice with DMEM (5 X 10 -8 X 106 cells/ml blood were recovered
under these conditions) . Tumors were finely minced with scalpels, the fragments disrupted in
a Tenbroeck homogenizer, and the debris in the resulting cell suspension (30 ml/tumor) was
allowed to sediment for 20 min at unit gravity . The supernates were then centrifuged at 600 g
for 10 min, the pellet was washed in DMEM, and the cells were suspended in 3 ml DMEM
containing 100 gg/ml DNase I (Worthington Biochemical Corp ., Freehold, N. J.) and 10mM
Hepes . After 30 min incubation at 37°C, the cells were washed once in 10 ml DMEM,
resuspended in 1 ml trypsin (0.5 mg/ml ; Difco Laboratories, Detroit, Mich.), and incubated for
5 min at 37°C . After two washes, the cells were resuspended in DMEM containing 10% FBS
(107 viable leukocytes were recovered per tumor under these conditions) .364
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Micro-MLTC
￿
As described previously (14), micro-MLTC were prepared in DMEM sup-
plemented with additional amino acids (16), 5 X 10-5M 2-mercaptoethanol, 10% FBS (culture
medium), to which 12-23% (vol :vol) secondary mixed leukocyte culture supernate (2° MLC
SN) as asource ofTCGF (17) was added . Each culture contained limiting numbersof responder
cells, 1 X 106 irradiated (2,000 rad) syngeneic spleen cells, and 3 X 104 irradiated (5,000 rad)
syngeneic (stimulator) MBL-2 tumor cells in a final volume of 0.2 ml in round-bottomed
microwells (Greiner, N6rtingen, Federal Republic of Germany) . After7dofculture, cell growth
was assessed microscopically and 100-p1 aliquots of effector cells were removed to measure
cytolytic activity .
Maintenance ofCTL Clones.
￿
CTL clones derived from microcultures were transferred to and
maintained in 1 .6-ml cultures that contained 5 X 106 irradiated (2,000 rad) syngeneic spleen
cells, and 3 X 10 5 irradiated (5,000 rad) syngeneic (stimulator) MBL-2 tumor cells in culture
medium supplemented with 25% 2° MLC SN in 16-mm multiwell plates (Costar, Data
Packaging, Cambridge, Mass . ; 15) . After initial expansion, clones were passaged every 4-5 dby
transferring 5 X 10 4 cells to fresh cultures . Aliquots of cells were periodically frozen at -80°C
in culture medium that contained 10% dimethyl sulfoxide and 50% FBS .
Assay for Cytolytic Activity . Cytolytic activity of effector cells was determined using a 5'Cr
release assay (18) . Briefly, aliquots of effector cells were mixed with either 2,000 or 10,000 5'Cr-
labeled tumor cells (as indicated) in a final volume of 200 gl in round-bottomed microplate
wells and incubated for 3.5 h at 37°C. The assay plates were then centrifuged, 100'tl of the
fluid was removed, and the amount of released 5'Cr was determined in a well-type gamma
counter . Controls included maximal release of 5'Cr represented by freeze-thawed target cells,
and spontaneous release of 5'Cr from labeled targets in the absence of effector cells .
Frequency ofCTL-P .
￿
The method used for the calculation ofCTL-P frequencies is described
in detail elsewhere (19) . Briefly, 24 replicate microcultures prepared with various numbers of
responding cells were assessed for cytolytic activity . Positive cultures were defined as those in
which the 5'Cr release values exceeded by 3 SD the spontaneous release values . Minimum
estimates ofCTL-P frequencies were calculated by analysis ofthe Poisson distribution relation-
ship between the number of responding cells per microculture and the percentage of nonre-
sponding cultures. Experimental values were fitted to the zero order term Poisson equation by
the minimum XZ method .
Fluorescent Staining and Flow Cytometric Analysis .
￿
Rat monoclonal antibodies directed against
Thy-1.2 (AT83) and Lyt-2 (53 .6.7) were kindly provided by Dr . F . Fitch and Dr .J. Ledbetter,
respectively . Purified IgG from BALB/c mice immunized with rat immunoglobulin waslabeled
with fluorescein isothiocyanate as described elsewhere (20) .
For fluorescent staining, lymphoid cells (0 .5 X 10 6-1 X 106 in 100 ltl) were first incubated
with anti-Thy-1 .2 (2 /-tg) or anti-Lyt-2 (undiluted hybridoma culture supernate) . Samples were
then washed andincubatedwith ^-20 hg ofthe fluoresceinated mouse anti-rat immunoglobulin .
All manipulations were carried out at 4°C.
All samples were run on a flow cytometer (FACS II ; B-D FAGS Systems, Mountain View,
Calif.) gated to exclude nonviable cells as described in detail elsewhere (21) . Fluorescence
histograms representing 1 X 10 4-4 X 104 viable cells were accumulated and arbitrarily
normalized .
Results
Frequency Estimation ofCTL-P in Tumor, Spleen, and Blood Obtained on Day 10 after MSV-
MoLVInjection . The frequencyofCTL-P contained in cell suspensions obtained from
pooled tumor tissue, spleen, or blood from groups of C57BL/6 mice given an
intramuscular injection of MSV-MoLV complex 10 d earlier was determined by
limiting dilution analysis . Various limiting numbers of responder cells from each pool,
3 X 10 4 irradiated syngeneic (MBL-2) lymphoma stimulator cells, and 106 irradiated
syngeneic spleen accessory cells were cultured for 7 d in 200 Al micro-MLTC in the
presence of 12-33% 2 ° MLC SN as a source of TCGF . The microcultures were then
scored microscopically for the presence of proliferating cells, and the CTL activity ofK. T. BRUNNER, H. R. MAcDONALD, AND J.-C. CEROTTINI
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each of the 24 replicate cultures was assayed individually by testing a fraction (e.g.,
100 1ul) against 2,000
5'Cr-labeled MBL-2 target cells. The remaining cells were
maintained for up to several days at 37°C to be available for selection and expansion.
Results of a representative experiment (Fig. 1) show that as few as 25 cells obtained
from the tumors generated positive microcultures with high cytolytic activity against
syngeneic MBL-2 tumor target cells, and that increasing numbers of responder cells
resulted in increasing numbers of positive microcultures. It can also be seen that 5- to
10-fold higher numbers of responder cells from spleen or blood had to be added to the
microcultures to obtain similar numbers of positive cultures. When minimum esti-
mates of CTL-P frequencies were calculated by analysis of the Poisson distribution
relationship between the percentage of nonresponding cultures per group and the
number of responding cells per microculture (Fig. 2), the frequency of CTL-P as
determined by the negative slope of the linear regression curves was found to be 1/67
for the tumors, 1/457 for the spleens, and 1/515 for the PBL, i.e., seven- to eightfold
higher in the tumors as compared with spleen and blood.
In five additional experiments identical to the one described in Figs. 1 and 2,
frequency estimates were performed on pools of tumor-derived cells, spleen cells, and
PBL of mice injected 10 d earlier with MSV-MoLV. Table I summarizes the results
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￿
Cytolytic activity of individual micro-MLTC prepared with (responder) cells obtained
from tumors, blood, or spleen of C57BL/6 mice injected 10 d earlier with MSV-MoLV complex.
Limiting numbers of responder cells were cultured in micro-MLTC with 3 X 10° irradiated
syngeneic MBL-2 lymphoma cells, 106 irradiated syngeneic spleen cells, and 12-33% (vol:vol) 2°
MLC SN. After 7 d incubation, sets of 24 replicate microcultures were assayed for cytolytic activity
against 2,000 5'Cr-labeled MBL-2 target cells in a 3.5-h test. The dotted line represents the mean
spontaneous 5'Cr-release plus 3 SD, determined in groups of 24 control cultures containing no
responder cells, but syngeneic tumor, syngeneic spleen, and 2 ° MLC SN. This defines the lower
limit of positive cytolytic activity. Maximal 5'Cr release was 1,254 cpm.366 CYTOLYTIC T LYMPHOCYTE PRECURSORS INFILTRATING TUMORS
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￿
Minimum estimate of the frequency ofCTL-P specific for syngeneic MBL-2 tumor cells in
cells obtained from tumors, blood, and spleen of C57BL/6 mice injected 10 d earlier with MSV-
MoLV complex. The frequency was calculated by fitting the experimental values presented in Fig.
1 to the zero order term Poisson equation by the minimum X2 method. The nonresponding cultures
are those that are negative for cytolytic activity against MBL-2 target cells.
TABLE I
Frequency of MoLV-specific c CTL-P in Spleen, PBL, and Tumor of
C57BL/6Mice on Day 10 after MSV-MoLV Injection
* Micro-MLTC were prepared with limiting numbers of responder cells from
spleens, PBL, and tumors as described for Fig. 1, and assessed for cytolytic
activity against "'Cr-labeled MBL-2 cells after 7 d. The percent negative
cultures at each cell dose was used to calculate the frequency of CTL-P by
the minimum XZ method.
$ Data from Fig. 2.
of all six experiments. It can be seen that the tumors consistently contained higher
frequencies of CTL-P than either spleens or PBL, and that the difference was on the
average 5- to 10-fold. These results suggest selective accumulation of tumor-specific
CTL-P in tumor tissue.
TCell Surface Markers on Tumor-derived Cells, Spleen Cells, andPBL.
￿
One explanation
for the increased frequency of CTL-P in tumor tissue could be the selective accumu-
lation (either specific or nonspecific) of a T cell subpopulation with the CTL-P surface
phenotype. Because CTL-P directed against alloantigens (21, 22) or against MSV-
associated antigens (K. T. Brunner, unpublished data) express both Thy-1 and Lyt-2
alloantigens, we therefore determined the proportion of cells in spleen, PBL, or tumor
Experiment Spleen PBL Tumor
1 1/918 1/876 1/102
2 1/944 1/552 1/141
3 1/936 1/360 1/98
4$ 1/457 1/515 1/67
5 1/1,031 1/242 1/53
6 1/936 1/468 1/85
Mean 1/806 1/430 1/83K. T. BRUNNER, H. R. MAcDONALD, AND J.-C. CEROTTINI
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bearing these markers. In particular, unselected lymphoid cells from each tissue were
stained with monoclonal rat antibodies directed against Thy-1 .2 or Lyt-2 followed by
fluoresceinated mouse anti-rat immunoglobulin. The murine second-step reagent was
chosen to eliminate problems with background staining of surface immunoglobulin-
positive B cells in the lymphoid suspensions. Samples were then run on a FAGS II
that was gated to exclude nonviable cells, and fluorescence histograms were obtained.
The results of one of two similar experiments performed are shown in Fig. 3 . It can
be seen that discrete biphasic fluorescence distributions were obtained with both
reagent combinations on all three cell populations tested. Quantitatively, the mono-
clonal anti-Thy-1.2 reagent was found to stain 13% of spleen cells, 35% of PBL, and
30% of tumor-infiltrating cells in the experiment shown in Fig. 3 . Using the anti-Lyt-
2 reagent, 5% of spleen cells, 13% of PBL, and 17% of tumor-derived cells were
stained. The results of both experiments are summarized in Table II. The relatively
low proportion of T cells obtained in spleen may simply reflect a dilution of T cells
due to the virus-induced splenic hyperplasia regularly observed in such animals.
Based on the surface phenotype results, CTL-P frequencies in spleen, PBL, and
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￿
T cell surface markers of MSV-MoLV immune cells. Suspensions of cells from spleen,
blood, or tumors ofC57BL/6 mice injected 10 d earlier with MSV-MoLV complex were incubated
with rat monoclonal antibodies directed against Thy-1 .2 or Lyt-2, followed by fluoresceinated mouse
anti-rat Ig. Stained samples were run on a FAGS II gated to exclude nonviable cells. Fluorescence
histograms are in each case compared with control samples stained with the anti-Ig reagent alone.
(The decreased intensity of anti-Lyt-2 fluorescence in the tumor cell population results from the
trypsin treatment) .368
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TABLE 11
CTL-P Frequencies in Spleen, PBL, and Tumor-derived Cells Normalized according to T Cell
Content*
* Data are from two independent experiments, corresponding to experiments 5 and 6 in Table I .
$ Percent positive cells as determined by flow microfluorometry .
§ CTL-P frequencies for each of the cell populations analyzed by flow microfluorometry are
expressed relative to the content ofThy-1+ or Lyt-2' cells .
tumor were recalculated to account for the relative T cell content in these tissues .
Such an analysis (Table II) revealed that CTL-P in tumor tissue were still five- to
eightfold enriched as compared with spleen or PBL when only Thy-1 + cells were
considered, and four- to sixfold enriched when the calculation was based only on Lyt-
2+ cells. It is noteworthy that, in absolute terms, about 1/9 Lyt-2' cells in the tumor-
derived population behaved operationally as a CTL-P, vs . an average of 1/45 and
1/41 for spleen and PBL, respectively . These phenotypic data thus confirmed that
CTL-P were in fact significantly enriched among tumor-infiltrating lymphoid cells .
Expansion of Clonal CTL Populations Isolated from Tumors and Determination of Cytolytic
Activity and Specificity. It was shown in a previous study that MoLV-specific CTL
populations obtained under limiting dilution (clonal) conditions from spleens of
regressor mice could be expanded by stimulation with irradiated syngeneic tumor
cells in 1.0-ml cultures containing irradiated syngeneic spleen cells and TCGF in the
form of 2' MLC SN (15) . Such expanded populations could then be recloned by the
limiting dilution technique and/or studied for cytolytic activity and specificity .
Following this approach, highly cytolytic microculture populations obtained from
limiting numbers of tumor-derived cells were selected in several experiments, and the
cells expanded . In a typical experiment, 6 of 12 microcultures selected for expansion
showed optimal proliferation, generating between 1 .2 X 106 and 2 .1 X 106 cells/
culture (average 1 .8 X 106) in 5 d . Fig . 4 shows the comparative cytolytic activity of
these expanded isolates against syngeneic MBL-2 lymphoma target cells . It can be
seen that five of the six populations showed high activity, leading to 50% lysis at
lymphocyte :target cell ratios of 0.5 :1 to 1 .1 :1 .
In an experiment designed to study the specificity of tumor-derived CTL clones,
micro-MLTC containing limiting numbers of responder cells were screened micro-
scopically on day 7 of incubation for proliferation, and 13 positive cultures were
randomly selected for expansion. Of these cultures, five responded optimally in two
successive restimulations . These five putative clones (Al, C5, El, D4, and C12) were
then tested for cytolytic activity against four tumor target cell types, i.e ., MBL-2
(H-2b), the syngeneic stimulating MoLV-derived lymphoma ; LSTRA (H-2d), an
allogeneic MoLV-derived lymphoma ; EL4 (H-2b), a syngeneic non-MoLV-derived
lymphoma, and P815 (H-2d), an allogeneic non-MoLV-derived tumor. To confirm
the sensitivity of CTL-mediated lysis of these different target cells, a spleen-derived
C57BL/6 anti-MSV clone (C1) that had been selected for cross-reactivity with H-2d
Cell population
Surface
Thy-1'
phenotyef
Lyt-2' Total
CTL-P/10' cells§
Thy-1' only Lyt-2' only
Spleen 13 ; 11 5 .1 ; 4.5 10; 11 77 ; 100 196; 244
PBL 35 ; 29 13 ; 12 41 ; 21 117 ; 72 315 ; 175
Tumor 30 ; 22 17 ; 11 190 ; 115 633 ; 523 1,118; 1,045w N
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Cytolytic activity of tumor-derived MoLV-specific CTL clones. The cytolytic activity of
six clones was assessed against 10,000 5'Cr-labeled MBL-2 tumor target cells in a 3.5-h assay.
alloantigens (14, 15) was included in the assay. As shown in Fig. 5, all five tumor-
derived populations showed exquisite specificity for the syngeneic MoLV-derived
tumor target, i.e., all showed strong cytolytic activity (50% lysis at lymphocyte :target
cell ratios ranging from 0.6:1 to 3 .2:1) against the syngeneic MoLV-derived MBL-2
targets only. The cross-reactive clone C1 showed strong cytolytic activity for P815
and MBL-2 target cells and weaker activity for LSTRA, but, as expected, it showed
no activity for the syngeneic non-MoLV-derived target EL4. As described previously,
the same EL4 cells are readily lysed by CTL directed against H-26 alloantigens (23) .
The present report demonstrates that MoLV-specific CTL-P contained in MSV-
MoLV induced tumors can be isolated, quantitated, and clonally analyzed by
applying a sensitive limiting dilution micro-MLTC technique. Our results obtained
in applying this technique show that tumor-infiltrating cells collected on day 10 after
MSV-MoLV injection (i.e., approximately at or close to the onset oftumor regression)
contained on the average fivefold higher CTL-P frequencies than either PBL or
spleen cells.
Previous studies in this system (5) had shown that tumor-derived cells were
heterogeneous, containing 52% lymphocytes (including 23% Thy-l + cells) . In the
present report, monoclonal antibodies directed against Thy-1 or Lyt-2 alloantigens
were used in combination with flow cytometric technology to further quantitate T
cell subsets in the tumor-derived cell population. We found that, on the average,
^-26% of tumor-derived cells expressed Thy-1 and 14% expressed Lyt-2, as compared
with 32% Thy-1' and 13% Lyt-2+ in the circulating peripheral blood. Thus it appears310
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FIG . 5 .
￿
Specificity of five tumor-derived CTL clones (Al, C5, El, D4, and C12) reactive with
MoLV-associated cell surface antigens . Micro-MLTC were prepared as indicated in Fig . 1, and 5 of
13 randomly selected cultures were expanded and assayed against 10,000 6'Cr-labeled MBL-2 ("),
LSTRA ("), EL4 (O), and P815 (A) target cells in a 3.5-h assay . A spleen-derived MOLV-specific
CTL clone (Cl) showing cross-reactivity with P815 and LSTRA target cells was assayed in parallel .
that the proportion of total T cells expressing Lyt-2 is slightly higher among tumor-
derived cells (54%) than among either PBL (39%) or spleen cells (40%) . Because
CTL-P reactive against alloantigens (21, 22) or MSV-associated antigens (K. T .
Brunner, unpublished data) are entirely contained within the Lyt-2+ subpopulation
ofT cells, it was considered important to base a comparison of CTL-P frequencies in
tumor-derived cells and PBL (or spleen) on their content in Lyt-2+ cells . When this
was done (Table II), the average CTL-P frequencies per Lyt-2+ T cell were found to
be 1/9 and 1/41 for tumor-infiltrating cells and PBL, respectively, i.e ., the frequency
was significantly (4.6-fold) higher in the tumor-derived population . These data thus
demonstrate a selective accumulation ofCTL-P in the tumor mass .K. T . BRUNNER, H . R . MAcDONALD, AND J.-C . CEROTTINI
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Earlier studies in the same system had shown that day 12 tumor-derived lymphoid
cell populations had higher cytolytic activities than regional lymph node cells from
the same animals, suggesting a selective accumulation of CTL in the tumors (5) .
However, PBL collected on day 9 were more active than either spleen or regional
lymph node cells, and a direct comparison of tumor-derived lymphoid cells and PBL
from the same tumor-bearing animals was not carried out . Furthermore, CTL assays
at the population level cannot distinguish between CTL with different cytolytic
activities and thus do not allow formal conclusions as to the frequency of CTL .
Although the precursor frequency assay used in the present study circumvents this
problem, it should nevertheless be noted that such assays provide minimum estimates
of the frequency of cells of the CTL lineage regardless of their state of differentiation,
i.e., they detect noncytolytic CTL-P as well as cytolytic CTL independently of their
killing efficiency (15, 24) . It may therefore be assumed that the CTL that can be
detected in tumor-infiltrating cells by a direct lytic assay are comprised in the
operationally defined CTL-P determined by the limiting dilution assay .
Our results showing lysis of syngeneic MoLV-derived target cells and lack of lysis
of MoLV-induced allogeneic or of syngeneic and allogeneic unrelated tumor target
cells by five (clonal) tumor-derived CTL populations (Fig . 5) confirm that H-2
restriction of clonal MoLV-specific CTL populations is not only valid for spleen-
derived (15, 25) but also for tumor-derived C57BL/6 effector cells . Because the five
CTL populations were randomly selected, it may be assumed that their specificity
was representative for the majority of the tumor-reactive CTL-P contained in the
tumor mass . In this context, it is worth mentioning that a minority of the MoLV-
specific CTL-P in C57BL/6 regressor spleens had been found to cross-react with
MoLV-induced allogeneic (H-2d) tumor cells or normal (uninfected) allogeneic (H-
2d) target cells (14, 15) . It remains to be determined whether such cross-reactiveCTL
are present in tumor-infiltrating cell populations . The five CTL populations tested
for specificity against four target cell types were obtained from an experiment in
which limiting numbers (25, 50, 100, and 150) of responding cells were placed in sets
of 24 micro-MLTC, and in which 17-37.5% of the microcultures were positive . On
statistical grounds, the probability that the five selected cultures were clonal thus
ranged from 79 to 91%_ However, the clonality ofthese populations was not considered
to be an issue for the present considerations, and no effort was made to reclone these
populations .
The approach used to isolate CTL-P directly from tumors by placing limiting
numbers of lymphoid cells isolated from homogenized and enzyme-treated tumor
tissue into micro-MLTC has several advantages . First, the extraction procedure is
simple and gives high yields of relatively pure leukocytes ; second, only tumor-specific
CTL-P proliferate under the microculture conditions used ; third, the frequency of
tumor-associated CTL-P (including CTL) can be estimated directly ; fourth, large
numbers of clonal CTL populations with the capability of continued proliferation
can readily be obtained for further study . In this context it was interesting to observe
that individual clones showed variable growth potential, some clones being lost after
one or several restimulations. In conclusion, direct isolation ofCTL clones from tumor
tissue, especially if shown to be applicable to other tumor systems, should greatly
facilitate further studies of the role ofCTL in tumor immunity, particularly concern-
ing the selective localization of CTL (and of potential helper T cells) in tumors, the372
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specificity repertoire of tumor-associated CTL,and the homing pattern and functional
activity of clonal CTL populations studied in transfer experiments .
Summary
A limiting dilution mixed leukocyte-tumor cell microculture system was used to
quantitate cytolytic T lymphocytes and their precursors (CTL-P), which infiltrate
tumors induced by injection of Moloney sarcoma-leukemia virus (MSV-MoLV)
complex into C57BL/6 mice . Leukocyte populations obtained from tumors collected
on day 10 after virus injection were found to contain significantly higher frequencies
of operationally defined (tumor-specific) CTL-P than either peripheral blood leuko-
cytes (PBL) or spleen cells from the same animals. When these frequencies were
normalized according to the content of Lyt-2+ T cells in each tissue, average CTL-P
frequencies were found to be 1/9 in tumor-infiltrating cells vs . 1/41 in PBL . These
results directly demonstrate selective accumulation ofCTL-P in the tumor mass.
A number of clonal isolates obtained from tumor-infiltrating leukocyte populations
were expanded and studied for cytolytic activity and specificity . Of 11 isolates, 10
were found to have high cytolytic activity, leading to 50% lysis of the syngeneic
MoLV-derived tumor target cells in 3.5 h at lymphocyte :target cell ratios ranging
from 0.5 :1 to 3 .2:1 . Furthermore, five randomly selected clones showed H-2 restriction
by their selective lytic activity against MoLV-derived syngeneic MBL-2 target cells
and their lack of activity against either MoLV-derived allogeneic (LSTRA) tumor
cells or against syngeneic (EL4) or allogeneic (P815) target cells unrelated to MoLV .
Receivedforpublication 2 April 1981 .
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